Regulation of neonatal immunity by let-7/Lin28
Regulation of neonatal immunity by let-7/Lin28
批准号:
9226046
负责人:
Brian David Rudd
金额:
$38.43万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2014
资助国家:
美国
项目状态:
已结题
起止时间:
2014-03-01 至 2019-02-28
关键词:
AdultAgeBiochemical PathwayBiological AssayBone Marrow Stem CellCD8-Positive T-LymphocytesCell CycleCell Differentiation processCell ProliferationCell Proliferation RegulationCell SurvivalCellsCyclin D1DevelopmentFRAP1 geneFamilyGenerationsGenesGeneticGenetic TranscriptionGenomicsGoalsGrowthHematopoietic stem cellsIGF1R geneImmunityImpairmentIndividualInfantInfectionInfectious AgentKnowledgeLifeLinkLiver Stem CellMaintenanceMammalsMemoryMemory impairmentMetabolicMetabolic PathwayMicroRNAsMorbidity - disease rateNeonatalOncogenesPIK3CG genePathway interactionsProliferatingPropertyRegulationReporterRepressionRoleSecondary ImmunizationSeedsT memory cellT-LymphocyteTSC1 geneTestingTherapeuticThymus GlandVaccinationVaccinesWorkagedcancer cellcell growthexperimental studyfetalgenome-wideglucose metabolismmetabolic profilemortalitymouse modelneonatal immunityneonatenovelpathogenpreventprogenitorprogramspublic health relevanceresponsesecondary infectionself-renewaltranscription factortranscriptome
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Neonates are highly susceptible to intracellular pathogens and develop poor immunity to infection. Since immunity against these infectious agents is largely dependent upon memory CD8+ T cells, we have performed detailed analysis of the CD8+ T cell response in early life and found that neonatal CD8+ T cells are intrinsically defective at differentiating into memory CD8+ T cells. Surprisingly, impaired memory formation by neonatal CD8+ T cells was not due to an inability to respond, rather neonatal CD8+ T cells proliferated more rapidly than adult cells and quickly became terminally differentiated. One of the most ancient and conserved regulators of proliferation and differentiation during early stages of development is the let-7 miRNA family. Let- 7 represses cell proliferation and growth by targeting many metabolic genes, cell cycle factors and oncogenes for repression. While let-7 is expressed at high levels in adult CD8+ T cells, its expression is blocked by Lin28b in neonatal CD8+ T cells, creating a genomic landscape that is highly conducive for rapid proliferation. Therefore, we believe that neonatal CD8+ T cells become more terminally differentiated and form poor memory cells, because of an inability to repress major transcriptional and metabolic pathways via let-7. Our proposal will test the hypothesis that different genetic programs, regulated by the let-7/Lin28b axis, alter the generation and maintenance of memory CD8+ T cells following neonatal infection. In the first aim (SA1), we will adjust expression levels of let7 and Lin28b in different aged CD8+ T cells and determine their role in neonatal and adult memory CD8+ T cell formation. In the last 2 aims (SA2 and SA3), we will identify the key transcription factors and metabolic pathways that are regulated by let-7/Lin28b and contributing to impaired development of memory CD8+ T cells in early life. Upon completion of this work, we will have obtained a complete mechanistic understanding of why neonatal CD8+ T cells fail to differentiate into memory and know whether correcting transcriptional and metabolic differences can restore protective immunity in early life. Our focus on let-7/Lin28b, which appears to regulate these differences, will allow us to manipulate the number and type of memory CD8+ T cells that are generated in specific ways. This is a novel and targeted approach to enhance memory T cell development in early life.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Developmental layers of CD8+ T cells in the lymph node
-
批准号:10648406
-
项目类别:
-
资助金额:$23.5万
-
财政年份:2023
-
负责人:Brian David Rudd
-
依托单位:
Impact of microbial exposure on immune development
-
批准号:9789838
-
项目类别:
-
资助金额:$46.53万
-
财政年份:2018
-
负责人:Brian David Rudd
-
依托单位:
Regulation of neonatal immunity by let-7/Lin28
-
批准号:8673294
-
项目类别:
-
资助金额:$38.47万
-
财政年份:2014
-
负责人:Brian David Rudd
-
依托单位:
Regulation of neonatal immunity by let-7/Lin28
-
批准号:9011997
-
项目类别:
-
资助金额:$47.31万
-
财政年份:2014
-
负责人:Brian David Rudd
-
依托单位:
Mechanisms limiting neonatal immunity
-
批准号:8805830
-
项目类别:
-
资助金额:$37.18万
-
财政年份:2014
-
负责人:Brian David Rudd
-
依托单位:
Mechanisms Limiting Neonatal Immunity
-
批准号:10623303
-
项目类别:
-
资助金额:$43.79万
-
财政年份:2014
-
负责人:Brian David Rudd
-
依托单位:
Mechanisms limiting neonatal immunity
-
批准号:8697640
-
项目类别:
-
资助金额:$38.6万
-
财政年份:2014
-
负责人:Brian David Rudd
-
依托单位:
Mechanisms limiting neonatal immunity
-
批准号:9015341
-
项目类别:
-
资助金额:$37.13万
-
财政年份:2014
-
负责人:Brian David Rudd
-
依托单位:
Mechanisms Limiting Neonatal Immunity
-
批准号:10408128
-
项目类别:
-
资助金额:$43.79万
-
财政年份:2014
-
负责人:Brian David Rudd
-
依托单位:
Mechanisms Limiting Neonatal Immunity
-
批准号:10183143
-
项目类别:
-
资助金额:$43.79万
-
财政年份:2014
-
负责人:Brian David Rudd
-
依托单位:
Mechanisms Limiting Neonatal Immunity
-
批准号:9789998
-
项目类别:
-
资助金额:$41.73万
-
财政年份:2014
-
负责人:Brian David Rudd
-
依托单位:
Neonatal Infections and Memory T c ell Repertoire R00
-
批准号:8517166
-
项目类别:
-
资助金额:$22.53万
-
财政年份:2011
-
负责人:Brian David Rudd
-
依托单位:
Neonatal Infections and Memory T c ell Repertoire R00
-
批准号:8335490
-
项目类别:
-
资助金额:$23.94万
-
财政年份:2011
-
负责人:Brian David Rudd
-
依托单位:
Neonatal Infections and Memory T c ell Repertoire R00
-
批准号:8317799
-
项目类别:
-
资助金额:$24.9万
-
财政年份:2011
-
负责人:Brian David Rudd
-
依托单位:
NIH PATHWAY TO INDEPENDENCE APPLICATION (K99/R00)
-
批准号:7869855
-
项目类别:
-
资助金额:$9.66万
-
财政年份:2010
-
负责人:Brian David Rudd
-
依托单位:
国内基金
海外基金
登录
查看更多内容
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
-
批准号:JCZRLH202601523
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
-
批准号:JCZRQN202500010
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:
-
依托单位:
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
-
批准号:2025JJ70209
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:雷芬芳
-
依托单位:
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
-
批准号:--
-
项目类别:面上项目
-
资助金额:--
-
批准年份:2024
-
负责人:万荣
-
依托单位:
甜茶抑制AGE-RAGE通路增强突触可塑性改善小鼠抑郁样行为
-
批准号:2023JJ50274
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2023
-
负责人:贺志明
-
依托单位:
蒙药额尔敦-乌日勒基础方调控AGE-RAGE信号通路改善术后认知功能障碍研究
-
批准号:--
-
项目类别:地区科学基金项目
-
资助金额:33万元
-
批准年份:2022
-
负责人:都义日
-
依托单位:
补肾健脾祛瘀方调控AGE/RAGE信号通路在再生障碍性贫血骨髓间充质干细胞功能受损的作用与机制研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:52万元
-
批准年份:2022
-
负责人:叶宝东
-
依托单位:
LncRNA GAS5在2型糖尿病动脉粥样硬化中对AGE-RAGE 信号通路上相关基因的调控作用及机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2022
-
负责人:于海兵
-
依托单位:
围绕GLP1-Arginine-AGE/RAGE轴构建探针组学方法探索大柴胡汤异病同治的效应机制
-
批准号:81973577
-
项目类别:面上项目
-
资助金额:55.0万元
-
批准年份:2019
-
负责人:辛贵忠
-
依托单位:
AGE/RAGE通路microRNA编码基因多态性与2型糖尿病并发冠心病的关联研究
-
批准号:81602908
-
项目类别:青年科学基金项目
-
资助金额:18.0万元
-
批准年份:2016
-
负责人:刘括
-
依托单位: